Advances in Brief Increased Expression of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Barrett ' s Esophagus and Associated Adenocarcinomas 1

Advances in Brief Increased Expression of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Barrett ' s Esophagus and Associated Adenocarcinomas 1
复制标题

DOI:
--
复制
发表时间:
2006
期刊:
--
影响因子:
--
通讯作者:
K. Wilson;Sidong;Fu;Kalathur;S. Ramanujam;Stephen;J. Meltzer
K. Wilson;Sidong;Fu;Kalathur;S. Ramanujam;Stephen;J. Meltzer
中科院分区:
其他
文献类型:
--
作者:
K. Wilson;Sidong;Fu;Kalathur;S. Ramanujam;Stephen;J. Meltzer

文献摘要

被引文献

相似文献

巴雷特食管是一种恶性前病变,由慢性反流性食管炎引起。诱导型一氧化氮合酶(±NOS;NOS-2)和环氧合酶-2 (COX-2)是炎症介质和上皮细胞生长调节剂。 nos和COX-2在结直肠腺瘤和癌中表达水平较高,而COX-2在胃癌中表达水平升高。为了确定 nos和COX-2在Barrett's相关肿瘤中的作用,我们测量了这些基因在化生的Barrett's和食管腺癌中的表达。我们分别在21例患者中16例(76%)和21例患者中17例(80%)检测到Barrett粘膜中±no和COX-2 niKNA水平高于配对的胃对照组织(两种基因的/ < 0.001)。在食管腺癌中,5例中有4例和5例中分别有±no和COX-2 inKNA水平升高。此外,在10名Barrett患者中,10名患者的免疫组化染色±no和COX-2表达强烈阳性,高于匹配的胃对照组。Western blotting证实COX-2表达升高。这些发现支持了 nos和COX-2在早期和经常参与Barrett相关肿瘤进展的假设。
Barrett's esophagus is a premalignant condition arising in response to chronic reflux esophagitis. Inducible nitric oxide synthase (¡NOS;NOS-2) and cyclooxygenase-2 (COX-2) are mediators of inflammation and regu lators of epithelial cell growth. Expression levels of ¡NOSand COX-2 are high in colorectal adenomas and carcinomas, and COX-2 expression is elevated in gastric cancers. To determine the involvement of ¡NOSand COX-2 in Barrett's-associated neoplasia, we measured expression of these genes in metaplastic Barrett's and esophageal adenocarcinomas. We de tected elevated ¡NOSand COX-2 niKNA levels in Barrett's mucosa com pared with paired gastric control tissues in 16 of 21 (76%) and 17 of 21 (80%) patients, respectively (/' < 0.001 for both genes). In esophageal adenocarcinomas, ¡NOSand COX-2 inKNA levels were increased in four of five and five of five cases, respectively. Furthermore, in 10 of 10 Barrett's patients, immunohistochemical staining for ¡NOSand COX-2 expression was strongly positive and higher than in matched gastric controls. Increased COX-2 expression was confirmed by Western blotting. These findings support the hypothesis that ¡NOSand COX-2 are involved early and often in Barrett's-associated neoplastic progression.